Ads
related to: astrazeneca careers portal
Search results
Results from the WOW.Com Content Network
AstraZeneca's primary listing is on the London Stock Exchange and is a constituent of the FTSE 100 Index; it also has a secondary listing on the Nasdaq Stockholm. It is also listed on the American Nasdaq and is a Nasdaq-100 company. AstraZeneca has one of the highest market capitalisations of pharmaceutical companies worldwide. [13]
He previously held the role of Executive Vice President, Innovative Medicines & Early Clinical Development (IMED) Biotech Unit of AstraZeneca from April 2010 to December 2018. Since Pangalos has been working at AstraZeneca, the company's compound success rate from pre-clinical studies to launch has increased from 4% to >19%. [ 13 ]
In August 2012 he was named as the new chief executive of AstraZeneca, [9] the world's fifth largest pharmaceutical company, when aged 53. He took up the post on 1 October 2012. He took up the post on 1 October 2012.
March started her scientific career at the London Hospital Medical College. [1] She was a graduate student at the University of London, where she studied immunology.In particular, she studied the properties of rheumatoid anti globulins and their role in the pathogenesis of rheumatoid arthritis. [2]
Alexion Pharmaceuticals, Inc., a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases.
Jane Osbourn, OBE, is a scientist and former chair of the UK BioIndustry Association. [1]A Natural Sciences graduate of Queens' College, Cambridge, Osbourn completed several post-graduate qualifications before moving into industry at Cambridge Antibody Technology, that became MedImmune and AstraZeneca.
London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.
He became Pfizer's Chief Scientific Officer and President of R&D on 26 May 2010, replacing Martin Mackay, who moved to the UK as head of research for AstraZeneca. On 14 May 2014 he appeared, with two other Pfizer executives, in front of the Science and Technology Select Committee to answer questions.
Ads
related to: astrazeneca careers portal